Chemical and structural analysis of an antibody folding intermediate trapped during glycan biosynthesis
Human IgG Fc glycosylation modulates immunological effector functions such as antibody-dependent cellular cytotoxicity and phagocytosis. Engineering of Fc glycans therefore enables fine-tuning of the therapeutic properties of monoclonal antibodies. The N-linked glycans of Fc are typically complex-ty...
Päätekijät: | Bowden, T, Baruah, K, Coles, C, Harvey, D, Yu, X, Song, B, Stuart, D, Aricescu, A, Scanlan, C, Jones, E, Crispin, M |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
American Chemical Society
2012
|
Samankaltaisia teoksia
-
Inhibition of mammalian glycan biosynthesis produces non-self antigens for a broadly neutralising, HIV-1 specific antibody.
Tekijä: Scanlan, C, et al.
Julkaistu: (2007) -
Antibodies expose multiple weaknesses in the glycan shield of HIV.
Tekijä: Crispin, M, et al.
Julkaistu: (2013) -
Antibodies expose multiple weaknesses in the glycan shield of HIV.
Tekijä: Crispin, M, et al.
Julkaistu: (2013) -
An endoglycosidase with alternative glycan specificity allows broadened glycoprotein remodelling.
Tekijä: Goodfellow, J, et al.
Julkaistu: (2012) -
Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies
Tekijä: Le, N, et al.
Julkaistu: (2016)